市场调查报告书

糖生物学的全球市场:至2025年的预测与市场机会

Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 934749
出版日期 内容资讯 英文 116 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

糖生物学的全球市场:至2025年的预测与市场机会 Global Glycobiology Market By Type of Enzyme, By Type of Kit, By Application, By End User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日内容资讯: 英文 116 Pages
简介

全球糖生物学市场,预计在预测期间内将以惊人的速度成长。全球糖生物学市场,是受到癌症、糖尿病、肾脏疾病等慢性疾病的盛行率增加所带动,也提高个人化医疗的需求。据此,全球的药物研发流程增加,预计给予在预测期间内的市场成长正面影响。

本报告提供全球糖生物学各市场市场区隔和各地区调查,市场规模及市场占有率的预测,推动因素与课题,市场趋势,竞争情形,企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19对全球糖生物学市场的影响

第4章 摘要整理

第5章 客户的回响

  • 品牌认知度
  • 产品认识
  • 顾客满意度分析
  • 未满足需求和课题

第6章 全球糖生物学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型(糖苷酶和神经氨酸酶,糖基转移酶和唾液酸转移酶,碳水化合物激酶,碳水化合物磺基转移酶,蛋白质磺基转移酶,其他)
    • 套件的各类型(聚糖释放套组,聚糖标记套组,聚糖纯化套组,其他)
    • 各用途(药物研发,疾病诊断,病毒学,细胞生物学,肿瘤学,其他)
    • 各终端用户(调查机关,诊断中心,医院,临床研究所,制药、生物科技企业,其他)
    • 各公司(2019年)
    • 各地区
  • 产品市场地图

第7章 亚太地区的糖生物学的市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型
    • 套件的各类型
    • 各用途
    • 各终端用户
    • 各国
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第8章 欧洲的糖生物学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型
    • 套件的各类型
    • 各用途
    • 各终端用户
    • 各国
  • 欧洲:国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第9章 北美的糖生物学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型
    • 套件的各类型
    • 各用途
    • 各终端用户
    • 各国
  • 北美:国家分析
    • 美国
    • 墨西哥
    • 加拿大

第10章 南美的糖生物学的市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型
    • 套件的各类型
    • 各用途
    • 各终端用户
    • 各国
  • 南美:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东、非洲的糖生物学市场展望

  • 市场规模与预测
  • 市场占有率与预测
    • 酵素的各类型
    • 套件的各类型
    • 各用途
    • 各终端用户
    • 各国
  • 中东、非洲:国家分析
    • 南非
    • 沙乌地阿拉伯
    • UAE
    • 科威特

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势与发展

第14章 竞争情形

  • Merck & Co., Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • New England Biolabs, Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Waters Corporation
  • Asparia Glycomics S.L.
  • Bruker Corporation
  • RayBiotech, Inc.
  • Z Biotech, LLC.
  • Chemily Glycoscience
  • Dextra Laboratories Ltd.
  • Lectenz Bio
  • Ludger Ltd
  • R&D Systems, Inc.
  • Bio-Techne
  • Danaher Corporation
  • S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • ProZyme

第15章 策略性推荐事项

第16章 免责声明

目录
Product Code: 4635

Global glycobiology market is expected to grow at a formidable rate during the forecast period. The global glycobiology market is driven by the growing prevalence of chronic diseases such as cancer, diabetics, renal diseases, among others, which has increased the demand for personalized medicines. This in turn has increased the drug discovery process around the globe, which is anticipated to positively impact growth of market during the forecast period. Also, increasing grants by different governments especially in the developing nations for R&D activities is further expected to bolster the growth of market over the next few years.

The global glycobiology market is segmented based on type of enzyme, type of kit, application, end user, company and region. Based on type of enzyme, the market can be categorized into glycosidases & neuramidases, glycosyltransferases & sialytransferases, carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases and others. The glycosidases & neuramidases segment is expected to dominate the market during the forecast period. This can be ascribed to their pivotal role in metabolism, antibacterial defense & pathogenesis, glycosidase probe design for ABPP represents an important task in chemical proteomic & glycomic research.

Regionally, the glycobiology market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to witness significant growth during the forecast period in the overall glycobiology market owing to the presence of many research laboratories and pharmaceutical and biotechnology companies in the region.

Major players operating in the global glycobiology market include Merck & Co., Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, New England Biolabs, Inc., Shimadzu Corporation, Takara Bio Inc., Waters Corporation, Asparia Glycomics S.L., Bruker Corporation, RayBiotech, Inc., Z Biotech, LLC., Chemily Glycoscience, Dextra Laboratories Ltd., Lectenz Bio, Ludger Ltd, R&D Systems, Inc., Bio-Techne, Danaher Corporation, S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), ProZyme and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new service developments. For instance, in 2018, Shimadzu Corp. collaborated with premier Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global glycobiology market from 2015 to 2018.
  • To estimate and forecast the market size of global glycobiology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global glycobiology market based on type of enzyme, type of kit, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global glycobiology market.
  • To identify drivers and challenges for global glycobiology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global glycobiology market.
  • To identify and analyze the profile of leading players operating in global glycobiology market.
  • To identify key sustainable strategies adopted by market players in global glycobiology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers of enzymes, kits & instruments used in glycobiology technique across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers of enzymes, kits & instruments used in glycobiology techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers of enzymes, kits & instruments used in glycobiology techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global glycobiology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Glycobiology enzymes, kits & instruments, manufacturers, suppliers, distributorsand other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to glycobiology
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers of enzymes, kits & instruments used in glycobiology techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global glycobiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Glycobiology Market, By Type of Enzyme:

Glycosidases & Neuramidases

Glycosyltransferases & Sialytransferases

Carbohydrate Kinases

Carbohydrate Sulfotransferases

Protein Sulfotransferases

Others

  • Global Glycobiology Market, By Type of Kit:

Glycan Releasing Kit

Glycan Labelling Kit

Glycan Purification Kit

Others

  • Global Glycobiology Market, By Application:

Drug Discovery

Disease Diagnostics

Virology

Cell Biology

Oncology

Others

  • Global Glycobiology Market, By End User:

Research Institutes

Diagnostic Centers

Hospitals

Clinical Laboratories

Pharmaceutical & Biotechnology Companies

Others

  • Global Glycobiology Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global glycobiology market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Glycobiology Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global Glycobiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Enzyme (Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Carbohydrate Kinases, Carbohydrate Sulfotransferases, Protein Sulfotransferases, Others)
    • 6.2.2. By Type of Kit (Glycan Releasing Kit, Glycan Labelling Kit, Glycan Purification Kit, Others)
    • 6.2.3. By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others)
    • 6.2.4. By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Glycobiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Enzyme
    • 7.2.2. By Type of Kit
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Glycobiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Enzyme
        • 7.3.1.2.2. By Type of Kit
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. India Glycobiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Enzyme
        • 7.3.2.2.2. By Type of Kit
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Glycobiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Enzyme
        • 7.3.3.2.2. By Type of Kit
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Glycobiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Enzyme
        • 7.3.4.2.2. By Type of Kit
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Glycobiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Enzyme
        • 7.3.5.2.2. By Type of Kit
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Europe Glycobiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Enzyme
    • 8.2.2. By Type of Kit
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Glycobiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Enzyme
        • 8.3.1.2.2. By Type of Kit
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Glycobiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Enzyme
        • 8.3.2.2.2. By Type of Kit
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Glycobiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Enzyme
        • 8.3.3.2.2. By Type of Kit
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Glycobiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Enzyme
        • 8.3.4.2.2. By Type of Kit
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Glycobiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Enzyme
        • 8.3.5.2.2. By Type of Kit
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. North America Glycobiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Enzyme
    • 9.2.2. By Type of Kit
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Glycobiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Enzyme
        • 9.3.1.2.2. By Type of Kit
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Glycobiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Enzyme
        • 9.3.2.2.2. By Type of Kit
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Glycobiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Enzyme
        • 9.3.3.2.2. By Type of Kit
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Glycobiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Enzyme
    • 10.2.2. By Type of Kit
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Glycobiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Enzyme
        • 10.3.1.2.2. By Type of Kit
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Glycobiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Enzyme
        • 10.3.2.2.2. By Type of Kit
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Glycobiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Enzyme
        • 10.3.3.2.2. By Type of Kit
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Glycobiology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type of Enzyme
    • 11.2.2. By Type of Kit
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Glycobiology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type of Enzyme
        • 11.3.1.2.2. By Type of Kit
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Glycobiology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type of Enzyme
        • 11.3.2.2.2. By Type of Kit
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Glycobiology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type of Enzyme
        • 11.3.3.2.2. By Type of Kit
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Kuwait Glycobiology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Type of Enzyme
        • 11.3.4.2.2. By Type of Kit
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Merck & Co., Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Thermo Fisher Scientific
  • 14.4. New England Biolabs, Inc.
  • 14.5. Shimadzu Corporation
  • 14.6. Takara Bio Inc.
  • 14.7. Waters Corporation
  • 14.8. Asparia Glycomics S.L.
  • 14.9. Bruker Corporation
  • 14.10. RayBiotech, Inc.
  • 14.11. Z Biotech, LLC.
  • 14.12. Chemily Glycoscience
  • 14.13. Dextra Laboratories Ltd.
  • 14.14. Lectenz Bio
  • 14.15. Ludger Ltd
  • 14.16. R&D Systems, Inc.
  • 14.17. Bio-Techne
  • 14.18. Danaher Corporation
  • 14.19. S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
  • 14.20. ProZyme

15. Strategic Recommendations

16. About Us & Disclaimer